CHLOROTHIAZIDE AND RESERPINE (CHLOROTHIAZIDE; RESERPINE) — FDA Approval ANDA088557 (HIKMA)
CHLOROTHIAZIDE AND RESERPINE (CHLOROTHIAZIDE; RESERPINE) — FDA Approval ANDA088557 (HIKMA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CHLOROTHIAZIDE AND RESERPINE; Active ingredients: CHLOROTHIAZIDE; RESERPINE; Application number: ANDA088557.
| Brand name | CHLOROTHIAZIDE AND RESERPINE |
|---|---|
| Active ingredients | CHLOROTHIAZIDE; RESERPINE |
| Application number | ANDA088557 |
| Sponsor | HIKMA |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19831222 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →